Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dabomb Protein Biotech's Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-63.3 Mil. Therefore, Dabomb Protein Biotech's EV-to-EBIT ratio for today is -17.40.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Dabomb Protein Biotech's Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-22.2 Mil. Therefore, Dabomb Protein Biotech's EV-to-EBITDA ratio for today is -49.47.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Dabomb Protein Biotech (ROCO:6578) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-63.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Dabomb Protein Biotech's EV-to-EBITDA for today is:
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-22.2 Mil.
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$309.3 Mil.
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$16.6 Mil.
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil.
Dabomb Protein Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-21.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dabomb Protein Biotech Enterprise Value Related Terms
Dabomb Protein Biotech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Dabomb Protein Biotech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6578 vs KHC, GIS: Enterprise Value Comparison
For the Packaged Foods subindustry, Dabomb Protein Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dabomb Protein Biotech Enterprise Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Dabomb Protein Biotech's Enterprise Value falls into.
Dabomb Protein Biotech Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Dabomb Protein Biotech's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NT$1,100.6 Mil mean?
Dabomb Protein Biotech (ROCO:6578) has a Enterprise Value of NT$1,100.6 Mil as of Jul. 07, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Enterprise Value too high?
Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Enterprise Value compare to KHC and GIS?
Dabomb Protein Biotech's Enterprise Value of NT$1,100.6 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Enterprise Value is NT$1,100.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.55, compared to a current price of NT$16.65 — trading 14.4% above its estimated fair value. The current Enterprise Value is NT$1,100.6 Mil. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Enterprise Value is NT$1,100.6 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?
Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued.
The current stock price of NT$16.65 is trading 14.4% above its estimated GF Value™ of NT$14.55.
GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.
Key valuation signals for ROCO:6578:
Enterprise Value: NT$1,100.6 Mil
GF Value™: NT$14.55 vs. price of NT$16.65 (14.4% above fair value)
No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score
Get the complete analysis for ROCO:6578
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6578 has been successfully added to your 
